Lam Anna, Küffer Thomas, Hunziker Lukas, Nozica Nikolas, Asatryan Babken, Franzeck Florian, Madaffari Antonio, Haeberlin Andreas, Mühl Aline, Servatius Helge, Seiler Jens, Noti Fabian, Baldinger Samuel H, Tanner Hildegard, Windecker Stephan, Reichlin Tobias, Roten Laurent
Department of Cardiology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
J Cardiovasc Electrophysiol. 2021 Jun;32(6):1610-1619. doi: 10.1111/jce.15064. Epub 2021 May 5.
Chemical ablation by retrograde infusion of ethanol into the vein of Marshall (VOM-EI) can facilitate the achievement of mitral isthmus block. This study sought to describe the efficacy and safety of this technique.
Twenty-two consecutive patients (14 males, median age 71 years) with attempted VOM-EI for mitral isthmus ablation were included in the study. VOM-EI was successfully performed with a median of 4 ml of 96% ethanol in 19 patients (86%) and the mitral isthmus was successfully blocked in all (100%). Touch up endocardial and/or epicardial ablation after VOM-EI was necessary for 12 patients (63%). Perimitral flutter was present in 12 patients (63%) during VOM-EI and terminated or slowed by VOM-EI in 4 and 3 patients, respectively. The low-voltage area of the mitral isthmus region increased from 3.1 cm (interquartile range [IQR] 0-7.9) before to 13.2 cm (IQR: 8.2-15.0) after VOM-EI and correlated significantly with the volume of ethanol injected (p = .03). Median high-sensitive cardiac troponin-T increased significantly from 330 ng/L (IQR: 221-516) the evening of the procedure to 598 ng/L (IQR: 382-769; p = .02) the following morning. A small pericardial effusion occurred in three patients (16%), mild pericarditis in one (5%), and uneventful VOM dissection in two (11%). After a median follow-up of 3.5 months (IQR: 3.0-11.0), 10 of 18 patients (56%) with VOM-EI and available follow-up had arrhythmia recurrence. Repeat ablation was performed in five patients (50%) and peri-mitral flutter diagnosed in three (60%).
VOM-EI is feasible, safe, and effective to achieve acute mitral isthmus block.
通过向马歇尔静脉逆行注入乙醇(VOM-EI)进行化学消融可促进实现二尖瓣峡部阻滞。本研究旨在描述该技术的有效性和安全性。
本研究纳入了22例连续尝试通过VOM-EI进行二尖瓣峡部消融的患者(14例男性,中位年龄71岁)。19例患者(86%)成功进行了VOM-EI,中位注入96%乙醇4毫升,所有患者(100%)均成功实现二尖瓣峡部阻滞。12例患者(63%)在VOM-EI后需要进行心内膜和/或心外膜补充消融。12例患者(63%)在VOM-EI期间出现二尖瓣环扑动,分别有4例和3例通过VOM-EI终止或减慢。二尖瓣峡部区域的低电压区从VOM-EI前的3.1厘米(四分位数间距[IQR] 0 - 7.9)增加到VOM-EI后的13.2厘米(IQR:8.2 - 15.0),且与注入乙醇的体积显著相关(p = 0.03)。高敏心肌肌钙蛋白-T中位数从手术当晚的330纳克/升(IQR:221 - 516)显著增加到次日早晨的598纳克/升(IQR:382 - 769;p = 0.02)。3例患者(16%)出现少量心包积液,1例(5%)出现轻度心包炎,2例(11%)VOM解剖无异常。在中位随访3.5个月(IQR:3.0 - 11.0)后,18例接受VOM-EI且有可用随访资料的患者中有10例(56%)出现心律失常复发。5例患者(50%)进行了重复消融,3例(60%)诊断为二尖瓣环扑动。
VOM-EI在实现急性二尖瓣峡部阻滞方面是可行、安全且有效的。